Kevin Tan

CIK: 0001884056

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (33.3%)

Position reduction

Option Exercises (M)6 (33.3%)

Derivative conversions

Awards (A)6 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SLDB

Solid Biosciences Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (18 total)

SLDB
Solid Biosciences Inc.
Feb 18, 2026
Sale(S)
Direct
5.4K shares at avg. $5.82$31K
SLDB
Solid Biosciences Inc.
Feb 13, 2026
Exercise(M)
Direct
10.6K shares-
SLDB
Solid Biosciences Inc.
Feb 4, 2026
Sale(S)
Direct
14.8K shares at avg. $6.44$95K
SLDB
Solid Biosciences Inc.
Feb 2, 2026
Sale(S)
Direct
26.8K shares at avg. $6.44$173K
SLDB
Solid Biosciences Inc.
Jan 31, 2026
Exercise(M)
Direct
33.1K shares-
SLDB
Solid Biosciences Inc.
Jan 29, 2026
Award(A)
Restricted Stock Units
Direct
56.6K shares-
SLDB
Solid Biosciences Inc.
Jan 29, 2026
Award(A)
Restricted Stock Units
Direct
93.5K shares-
SLDB
Solid Biosciences Inc.
Jan 29, 2026
Exercise(M)
Direct
56.6K shares-
SLDB
Solid Biosciences Inc.
Jan 29, 2026
Award(A)
Employee Stock Option (Right to Buy)
Direct
187K shares-
SLDB
Solid Biosciences Inc.
Jan 13, 2026
Sale(S)
Direct
5.7K shares at avg. $5.27$30K
SLDB
Solid Biosciences Inc.
Jan 9, 2026
Exercise(M)
Direct
11.3K shares-
SLDB
Solid Biosciences Inc.
Aug 14, 2025
Award(A)
Restricted Stock Units
Direct
62.5K shares-
SLDB
Solid Biosciences Inc.
Aug 14, 2025
Award(A)
Employee Stock Option (Right to Buy)
Direct
125K shares-
SLDB
Solid Biosciences Inc.
Feb 14, 2025
Sale(S)
Direct
3.2K shares at avg. $3.96$13K
SLDB
Solid Biosciences Inc.
Feb 13, 2025
Exercise(M)
Direct
10.6K shares-
SLDB
Solid Biosciences Inc.
Jan 31, 2025
Award(A)
Restricted Stock Units
Direct
132.3K shares-
SLDB
Solid Biosciences Inc.
Jan 10, 2025
Sale(S)
Direct
4.1K shares at avg. $3.89$16K
SLDB
Solid Biosciences Inc.
Jan 9, 2025
Exercise(M)
Direct
11.3K shares-

		Type	Shares	Price		Ownership
Feb 18, 2026	SLDB Solid Biosciences Inc.	Sale(S)	5,404	$5.82	$31,469	Direct
Feb 13, 2026	SLDB Solid Biosciences Inc.	Exercise(M)	10,625	-	$0	Direct
Feb 4, 2026	SLDB Solid Biosciences Inc.	Sale(S)	14,783	$6.44	$95,231	Direct
Feb 2, 2026	SLDB Solid Biosciences Inc.	Sale(S)	26,837	$6.44	$172,747	Direct
Jan 31, 2026	SLDB Solid Biosciences Inc.	Exercise(M)	33,075	-	$0	Direct
Jan 29, 2026	SLDB Solid Biosciences Inc.	Award(A) Restricted Stock Units	56,647	-	-	Direct
Jan 29, 2026	SLDB Solid Biosciences Inc.	Award(A) Restricted Stock Units	93,500	-	-	Direct
Jan 29, 2026	SLDB Solid Biosciences Inc.	Exercise(M)	56,646	-	$0	Direct
Jan 29, 2026	SLDB Solid Biosciences Inc.	Award(A) Employee Stock Option (Right to Buy)	187,000	-	-	Direct
Jan 13, 2026	SLDB Solid Biosciences Inc.	Sale(S)	5,704	$5.27	$30,060	Direct
Jan 9, 2026	SLDB Solid Biosciences Inc.	Exercise(M)	11,250	-	$0	Direct
Aug 14, 2025	SLDB Solid Biosciences Inc.	Award(A) Restricted Stock Units	62,500	-	-	Direct
Aug 14, 2025	SLDB Solid Biosciences Inc.	Award(A) Employee Stock Option (Right to Buy)	125,000	-	-	Direct
Feb 14, 2025	SLDB Solid Biosciences Inc.	Sale(S)	3,164	$3.96	$12,529	Direct
Feb 13, 2025	SLDB Solid Biosciences Inc.	Exercise(M)	10,625	-	-	Direct
Jan 31, 2025	SLDB Solid Biosciences Inc.	Award(A) Restricted Stock Units	132,300	-	-	Direct
Jan 10, 2025	SLDB Solid Biosciences Inc.	Sale(S)	4,073	$3.89	$15,849	Direct
Jan 9, 2025	SLDB Solid Biosciences Inc.	Exercise(M)	11,250	-	$0	Direct

1-18 of 18 transactions

About Tan Kevin

Tan Kevin (SEC CIK 0001884056) files insider reports with the SEC as CFO & Treasurer of Solid Biosciences Inc. (SLDB).

Signal8 holds 9 ownership filings by Tan Kevin, all Form 4s, filed between Jan 13, 2025 and Apr 21, 2026. Those filings report 18 transactions, from Jan 9, 2025 to Feb 18, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Tan Kevin's filings is in CHARLESTOWN, MA.

Recent filings by Tan Kevin

Feb 18, 2026: Open-market sale of SLDB shares (Form 4, code S).
Feb 13, 2026: Option exercise of SLDB shares (Form 4, code M).
Feb 4, 2026: Open-market sale of SLDB shares (Form 4, code S).
Feb 2, 2026: Open-market sale of SLDB shares (Form 4, code S).
Jan 31, 2026: Option exercise of SLDB shares (Form 4, code M).

Other insiders filing for Solid Biosciences Inc. (SLDB)

Ganot Ilan, Director
Brooks Gabriel, Chief Medical Officer
SMITH IAN F, Director
RA CAPITAL MANAGEMENT, L.P., 10% Owner
Nagendran Sukumar, Director
PERCEPTIVE ADVISORS LLC, Director

How to read Form 4 transaction codes